Produktname:(E)-N'-(2-cyano-4-(3-(1-hydroxy-2-methylpropan-2-yl)thioureido)phenyl)-N,N-dimethylformimidamide

IUPAC Name:1-{3-cyano-4-[(E)-[(dimethylamino)methylidene]amino]phenyl}-3-(1-hydroxy-2-methylpropan-2-yl)thiourea

CAS:1429755-57-6
Molekulare Formel:C15H21N5OS
Reinheit:95%+
Katalognummer:CM329512
Molekulargewicht:319.43

Packungseinheit Verfügbarer Vorrat Preis($) Menge
CM329512-250g in stock ǙľƿŹ
CM329512-500g in stock ǪIJƈŗ
CM329512-1000g in stock ƿȃǙIJ

Nur für den Einsatz in Forschung und Entwicklung..

Anfrage-Formular

   refresh    

Produkt-Details

CAS-Nr.:1429755-57-6
Molekulare Formel:C15H21N5OS
Schmelzpunkt:-
SMILES-Code:CN(C)/C=N/C1=CC=C(NC(NC(C)(C)CO)=S)C=C1C#N
Dichte:
Katalognummer:CM329512
Molekulargewicht:319.43
Siedepunkt:
Mdl-Nr.:
Lagerung:Keep in a tight container and store at abient temperature

Column Infos

Tucatinib
In August 2023, phase III results for tyrosine kinase inhibitor Tukysa (tucatinib), in combination with antibody-drug conjugate Kadcyla (ado-trastuzumab emtansine), which met its primary endpoint of progression-free survival in HER-2 breast cancer patients.
TUKYSA (tucatinib) is an oral medicine that is a tyrosine kinase inhibitor of the HER2 protein. It is approved in more than 40 countries.